Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Neurotrophic and Neuroprotective effects of muscle contraction.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Full Prescribing Information, Copaxone (glatiramer acetate)
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
The "poison chair" treatment for multiple sclerosis.
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Policy: NIH to balance sex in cell and animal studies.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.

Pages